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A B S T R A C T
Objective: The aim of the present study was to evaluate complaints in people with Ménière’s
disease (MD) with and without migraine and headache to study the association between MD and
Vestibular Migraine (VM). We believe this will help us understand if these two disorders represent a
disease continuum in that they may share a common aetiology.
Methods: The study used a retrospective design and included data of 911 patients with MD from the
Finnish Ménière Federation database. The study participants had a mean age of 60.2 years, mean
duration of disease of 12.6 years, and 78.7% of the participants were females. The questionnaire data
comprised of both disease specific and impact related questions. The data were analyzed using the
Mann–Whitney U test, the Kruskal Wallis H test, logistic regression analyses, and decision treeanalysis.
Results: Migraine and headache was reported by 190 subjects (20.9%) and 391 subjects (42.9%)
respectively. We found that patients that could be classified as VM in the study (i.e., those with
frequent vertigo spells associated with migraine) more often reported complaints of severe MD
symptoms, had reduced health-related quality of life, suffered more from anxiety, had more
neurological complaints, and experienced a reduced sense of coherence than the non-migraneous
patients with MD. However, neither the decision tree analysis nor the logistic regression analysis
could reliably discriminate VM from MD patients.
Conclusion: Our study results confirm that MD is frequently associated with headache and migraine.
In addition, results also indicate that migraine provokes the severity of MD. We suggest that MD and
VM may share similar pathophysiological mechanisms. Hence, the future MD classification systems
should include a category referred to as ‘MD with migraine’ that will include patients with VM.
© 2019 Elsevier B.V. All rights reserved.
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The cardinal symptoms of Ménière’s disease (MD) consists of
episodic vertigo, fluctuating hearing loss and tinnitus [1]. People* Corresponding author.
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0385-8146/© 2019 Elsevier B.V. All rights reserved.with MD also oftencomplain of fullness in theear, vestibular drop
attacks, gait problems, postural instability and nausea. MD is a
chronic illness affecting about 190 per 100,000 patients in a US
Health-claims database, but in population studies a prevalence of
513/100,000 has been shown [2]. MD originates in the inner ear
and can be demonstrated as an enlargement of the endolymphatic
space causing endolymphatic hydrops in histological studies [3],énière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
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and the condition has a chronic course. Having a genetic
background, viral sequal and autoimmunity have been suggested
as possible aetiologias for MD [1], leading to ailment of the
peripheral nerve endings [4]. The diagnosis is based on symptom
complex classified by American academy of Otolaryngology —
Head and Neck Surgery [5] in four categories. In definite MD, the
complaints consist of at least two rotatory vertigo attacks lasting
for more than 20 min, tinnitus or fullness of the ear, and
documented hearing loss in the audiogram. The AAO-HNS
definition of MD has been recently modified by the committee
members of Barany Society by reducing the categories to
“probable MD” and “definite MD” [6].
Migraine is also reported to cause dizziness and vertigo and
is overrepresented among patients with MD [7–9]. Migraine
Associated Vertigo was jointly classified by the Bárány Society
and the International Headache Society, and was consequently
re-named as Vestibular Migraine (VM) [9]. VM is classified
entirely on the basis of clinical features as reported by the
patient. The diagnosis of VM is based on recurrent vestibular
symptoms, a history of migraine, a temporal association
between vestibular symptoms, and exclusion of other causes of
vestibular symptoms. Symptoms that qualify for a diagnosis of
VM include various types of vertigo as well as head motion-
induced dizziness with nausea. Headache must be of moderate
or severe intensity, and the duration of acute episodes is limited
to a window of between 5 min and 72 h in order to qualify for a
diagnosis of VM [9]. Profound abnormalities in the symptom-
free interval, such as severe hearing loss and complete unilateral
or bilateral vestibular loss are usually indicative of another
cause [9]. The concept of brain stem ischemia, which was
popular several decades ago, as evidenced by the terms,
“vascular headache” [10] and “basilar artery migraine,” has
largely been supplanted by neurochemical theories that may or
may not include a vascular component [11–13]. Phillips et al.
[14] indicated that cortical spreading depression causing
neuronal and glial depolarization represents the most likely
explanation for migraine aura. Brainstem depression solely in
the regions of the vestibular nuclei without affecting other brain
stem nuclei is implausible [12]. Moreover, family history is
often positive for both disorders, suggesting that an inherited
syndrome exists which would include a variable expression of
migraine and Meniere’s features [15]. However, no common
genes have been found so far, and the genetics of vestibular
migraine are heterogeneous, uncertain, and complicated [16].
Hitherto, there are no objective measurements confirming or
rejecting the diagnosis of VM from inner ear disease causing
vertigo and dizziness as MD (for review See - Tabet and Saliba
[17]). Therefore, researchers have tried to show that migraine is
a likely cause of vertigo or dizziness by using two approaches.
One approach has been to study randomly selected patients with
typical migraine headaches to demonstrate that vertigo and
dizziness occur more frequently in migraine patients than in the
general population [18,19], while the other method is to study
patients with defined vertigo and look for association with
migraine [20,21]. Both of these approaches have indicated that
there is an overexpression of patients with vertigo among VM;
on the other hand, in MD there exists an overrepresentation ofPlease cite this article in press as: Pyykkö I, et al. Association between M
https://doi.org/10.1016/j.anl.2019.02.002patients with migraine. Vestibular symptoms in VM have been
reported to occur before the headache in a pattern similar to an
aura, during the headache, but also completely independent of
the headache [22]. In a review, Tabet and Saliba [17] evaluated
published research dealing with MD and migraine to study the
association of MD with VM. Unfortunately, there is much
overlapping with regard to symptomatology for these two
conditions, thus creating diagnostic uncertainty. In fact, some
articles excluded the overlap group while others did not
consider them. For example, Neff et al. [21] demonstrated that
none of the signs, symptoms or investigations could distinguish
MD and VM from each other. Almost all of these studies have
been carried out without a temporal association of migraine
attacks with vertigo attacks, thus creating an uncertainty
regarding the coexistence of vertigo and migraine.
Inner ear MRI has been carried out in two studies in order to
compare differences between MD and VM. In the study of
Nakada et al. [23], both the VM and MD demonstrated a high
prevalence of the presence of endolymphatic hydrops in the
inner ear. In another study, conducted by Gürkov et al. [24], it
was demonstrated that VM had a less frequent prevalence
of endolymphatic hydrops than in MD. In VM, transient
endolymphatic hydrops has also been described [25]. The
challenges in diagnosis of MD and VM has been highlighted by
Phillips et al. [14], who has criticized the loosely assessed
diagnoses of vertigo attacks with migraine, and thus stated that
VM has emerged as a popular diagnosis to fill the void left by
the entity known as “vestibular MD” to search for a better
explanation. Some authors have even gone as far as suggesting
that “vestibular MD” based on AAO-HNS earlier classification
[26] is actually undiagnosed VM [27]. It seems that the concept
of “vestibular MD” indicates that there exists a subgroup of
patients with “possible MD” (as in about 20% of patients) in
which the complete triad of MD [28] takes more than 5–10
years to develop. The symptom-based classifications make the
diagnostic work up of individual patients difficult [24,29].
The aim of the present study was to evaluate complaints in
people with MD who are presented with and without migraine
and headache in order to study the association between MD and
VM. In particular, we used the temporal association to evaluate
whether the complaints of MD, headache and migraine differ
between patients classified as MD. We hypothesized that by
examining the differences and similarities in MD and VM, we
may understand if these two disorders represent a disease
continuum in that they may share a common aetiology.
2. Method
2.1. Study design and participants
The study used a retrospective design. Permission was
obtained from the Finnish Ménière Federation (FMF; Suomen
Meniere-liitto) to allow access to the FMF registry data
anonymously (i.e., without the personally identifiable informa-
tion of subjects). The registry data contained detailed data on
disease that the FMF had collected from their members when
establishing the computer based diagnostic and peer support
program during the years 2005–2016 [30–35]. Under Finnishénière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
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association does not require ethical approval. The data was
collected from 961 of the 1646 FMF members. From the
existing data, information about the diagnosis of migraine was
missing in 50 subjects and therefore 911 patients were included
in the current study. The mean age of the participants was
60.2 years (range–80 years, SD = 12.1 years). The duration of
the disease on average was 12.6 years (range 0.5–50 years,
SD = 11.2 years). Participants included 717 females (i.e.,
78.7%) and 194 males (i.e., 21.3%) respecting the gender
distribution of FMF and prevalence of MD in Finland [2].
2.2. Data collection
All of the questionnaires were administered in Finnish. The
questionnaireswerecomprisedofbothdiseasespecificand impact
related questions including: (1) an oto-neurology questionnaire
[36–38]; (2) EuroQolEQ-5D-3L general-health related quality of
life measure [39]; (3) sense of coherence [40]; and (4) specific
questions on anxiety or nervousness and vitality taken from the
general health related quality of life instrument 15D [41].
Attitude toward illness is one of the key elements in
determining the individual’s ability to cope with the illness
[42]. Antonovsky [40] developed the concept of the sense of
coherence to define salutogenesis i.e., the means of helping
oneself through the difficulties of life. The sense of cohe-
rence consists of three main components, which include: (a)
cognitive component — the ability to understand what is
happening; (b) manageability component — the manage-
ability of life situations in social networks; and (c) the
meaningfulness component — the ability to a find meaning
in life. The sense of coherence has been shown to be a
critical variable in predicting treatment outcomes, especial-
ly in terms of psychosocial adaptation and subjective
adaptability to a medical condition. The sense of coherence
score is stable when it is high, while a low sense of
coherence is more likely to improve on acquiring more life
experience. In MD, Ketola et al. [43] showed that coping
with MD is better in those having a higher sense of
coherence scores indicating that a higher sense of coherence
may reflect positive optimism, which may indicate accep-
tance and subsequently better management of restrictions
caused by MD.
The oto-neurology questionnaire consisted of 102 items
and covered all elements of the disease including onset of the
complaints, characterization of vertigo, balance problems,
mobility related problems, hearing loss, tinnitus and
hyperacusis, and associated complaint. In the disease-
specific impact evaluation, the patients were asked to rate
the impact caused by MD by different complaints in a four-
point Likert scale. The diagnosis of migraine was based on
previous medical evaluations mostly carried out by neurol-
ogists. We also used a question to confirm the diagnosis of
migraine: Do you have migraine which has been diagnosed
by a physician? Headache was queered with 4 questions.
Questions about migraine included: How often does the
headache occur? and How long does the headache last?
Possible association of headache with vertigo spells werePlease cite this article in press as: Pyykkö I, et al. Association between M
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vertigo attacks? Based on the responses to these questions,
participants were classified into five groups. The question-
naire also included questions about neurological symptoms,
history of general health, family history, metabolic and
cardiovascular diseases, possible use of ototoxic or vestibu-
lotoxic drugs, history of possible inner ear injuries and head
and neck injuries, ear surgeries and other diseases that may
influence balance. Finally, the questionnaire contained
questions related to symptoms and their effects on life in
addition to questions related to personal characteristics.
2.3. Data analysis
The data were analyzed using various non-parametric and
parametric statistics. The Mann–Whitney U test and the
Kruskal Wallis H test were used to investigate the association
between demographic details as well as complaints about the
disease. In the results, the Chi square value instead of ranks are
provided to illuminate the strength of the association. The
between group comparison was made with the Mann–Whitney
test. The dependencies between these factors were examined
using logistic regression analysis. For continuous variables we
used analysis of variance (ANOVA) in statistical comparison.
The association of specific complaints were analyzed with
logistic regression analyses. In classification of the variables
between complaints of migraneous patients with frequent
vertigo and those without migraine associated vertigo used
decision tree analysis. A p-value of 0.05 was used for
interpretation of statistical significance.
3. Results
3.1. Characteristic of pain in the head and association with
vertigo
The association of vertigo attacks with migraine or headache
was scaled as no, rarely, moderately often, frequently, and very
frequently (See Table 1). No headache associated with vertigo
was reported by 518 subjects (56.9%), rarely by 194 subjects
(21.3%), moderately often by 126 subjects (13.8%), frequently
by 56 subjects (6.1%), and very frequently by 17 subjects
(1.9%). As the association of vertigo with migraine is one of the
key criteria in establishing the diagnosis of VM, we analyzed
the occurrence of vertigo with headache and migraine by
dividing the association into two groups: (a) those with no
association or rare association; and (b) those with vertigo
occurring with migraine moderately often, frequently, and very
frequently. The patients with migraine did not differ from those
with headache by having more frequent association with vertigo
(Mann–Whitney test, Z = 1.189, p = 0.23).
Pain in the head (headache or migraine) occurred less than
annually in 37 subjects (4.1%), less than once in a month by
207 subjects (22.7%), occurring monthly by 190 subjects
(20.7%), occurring weekly by 113 subjects (12.5%), and daily
by 34 subjects (3.7%). The pain lasted less than 2 h by
260 subjects (28.5%), lasted more than 2 h but less than 24 h by
292 subjects (32.1%), and longer than 24 h or constant pain byénière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
Table 1
Association of headache with vertigo spells (Note: Individuals reporting rarely having vertigo with headache is classified as not being associated with vertigo).
Association rating No headache
(n = 330)
Headache not assoc.
vertigo (n = 267)
Headache with
vertigo (n = 124)
Migraine not ass.
vertigo (n = 115)
Migraine with
vertigo (n = 75)
All (%)
No vertigo with headache 330 132 0 56 0 518 (56.9%)
Rarely vertigo with headache 0 135 0 59 0 194 (21.3%)
Moderately often vertigo with headache 0 0 83 0 43 126 (13.8%)
Frequently vertigo with headache 0 0 31 0 25 56 (6.1%)
Very frequently vertigo with headache 0 0 10 0 7 17 (1.9%)
Total 330 (36.22%) 267 (29.3%) 124 (13.61%) 115 (12.62%) 75 (8.23%) 911 (100%)
I. Pyykkö et al. / Auris Nasus Larynx xxx (2019) xxx–xxx4
G Model
ANL-2581; No. of Pages 1029 subjects (3.2%). Migraine and headache were reported by
190 subjects (20.9%) and 391 subjects (42.9%) respectively. No
pain was reported by 330 subjects (36.2%). There was no
difference between the migraine patients and headache patients
in the frequency of the pain attacks (Mann–Whitney test,
Z = 1.189 = 3, p = 0.235), but patients with migraine without
associated vertigo had longer duration than the patients with
headache (Mann–Whitney test, Z = 3.13, p = 0.001).Fig. 1. Characteristics concordant with the frequency of vertigo attacks (Fig. 1a), du
between groups of patients classified based on association of vertigo on patients with
confidence interval (CI) are shown. The complaints are rated in a 5-point scale fr
Please cite this article in press as: Pyykkö I, et al. Association between M
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balance
We analyzed the characteristics of vertigo attacks and
complaints related to postural instability using the Kruskal–
Wallis test (Figs. 1 and 2). The study subjects were divided into
5 groups based on headache and migraine shown in Table 1. The
Kruskal–Wallis test showed a statistically significant differenceration of vertigo attacks (Fig. 1b), and intensity of the vertigo attacks (Fig. 1c)
 no headache, with/without headache and with/without migraine. Mean and 95%
om non to very frequent, very long, or very intense.
énière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
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p = 0.005) (Fig. 1a), duration of vertigo attacks (Chi square =
18.547, p = 0.001) (Fig. 1b), intensity of vertigo attacks (Chi
square = 15.156, p = 0.004) (Fig. 1c), unsteadiness between the
attack (Chi square = 40.773, p < 0.001) (Fig. 2a), and mobility
outside of the attacks (Chi square = 30.691, p < 0.001) (Fig. 2b).
In comparison of migrenous patients with or without frequent
association with vertigo, only mobility outside of vertigo attack
tended to be statistically significant (Mann–Whitney test,
Z = 2.44, p = 0.015).
3.3. Association of headache and migraine with neurological
complaints
We analyzed possible neurological complaints between
the no-headache and migraine group (Fig. 3). In all variables
selected as blurring of vision or double vision (Chi square =
30.599, p < 0.001) (Fig. 3a), weakness of voice, stuttering
or blurring of speech (Chi square = 48.481, p < 0.001)
(Fig. 3b), difficulties in swallowing (Chi square = 38.556,
p < 0.001) (Fig. 3c), and tingling in face or disturbance of
sensitivity (Chi square = 59.346, p < 0.001) (Fig. 3d) were
factors found to have statistically significant associations with
different patient groups. However, there were no differences
between headache and migraine groups found in the secondary
analysis.
3.4. Quality of life
In the individual components of EuroQolEQ-5D-3L, all
variables except the mood variable differed significantly among
the groups (Fig. 4). The outcome scores of EQ-5D-3L
instruments differed significantly between the no-headache,
headache and migraine groups (F = 16.01, p < 0.001) (Fig. 4a)
and this difference was also observed in the EuroQol VAS
instrument (F = 9.26, p < 0.001) (Fig. 4b).Fig. 2. Characteristics concordant with the unsteadiness between attacks (Fig. 2a) an
on patients classified based on association of vertigo on patients with no headache, 
interval (CI) are shown. The complaints are rated in a 5-point scale from none to 
Please cite this article in press as: Pyykkö I, et al. Association between M
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We evaluated the association of personal trait measured
using the sense of coherence scale in patients with no headache,
headache and migraine. The patients with migraine and
frequent vertigo had the lowest scores in the sense of coherence
instrument, and a statistically significant difference was
observed among the groups (F = 9.34, p < 0.001) (Fig. 5a).
The best scores were among patients without headache and the
worst scores among patients with migraine associated vertigo
(Fig. 5a).The outcome of replies on anxiety indicated some
differences between groups (Chi square = 35.4, p < 0.001)
(Fig. 5b). Patients with vertigo associated with migraine attacks
suffered from greater anxiety than non-headache patients
(p < 0.001) or patients with headache not associated with
vertigo (p = 0.007). The outcome of replies on fatigue indicated
in MD with migraine attacks suffered from fatigue (Chi
square = 55.1, p < 0.001) (Fig. 5c). In pairwise comparison, the
patients with migraine and headache associated with vertigo
experienced greater fatigue than non-headache patients (p
< 0.001) or patients with headache not associated with vertigo
(p = 0.03).
3.6. Modelling migraine associated vertigo
We classified patients with frequent association of vertigo
with migraine in a decision tree analysis to evaluate what
characteristics in MD could be related to VM. In the model,
only a few factors were significant, and the most important was
“paresthesia of the face (Chi square = 21.251, p < 0.001). The
next node “syncope during attack” was also significant (Chi
square = 9.265, p = 0.007), and was more severe in migrainous
vertigo patients. The parallel node “feeling of drunkenness  was
more common in migrainous vertigo patients (Chi square =
11.167, p = 0.001). Finally, “Tumarkin attacks leading to slips
or falls” tended to be more common in migraneous patients (Chid mobility problems (Fig. 2c), and classified based on the association of vertigo
with/without headache, and with/without migraine. Mean and 95% confidence
very intense.
énière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
Fig. 4. Quality of life among patients with Meniere’s disease classified based on vertigo associated headache. EQ-5D-3L instrument (Fig. 4a) and EQ-5D-3L VAS
instrument (Fig. 4b) are classified based on the association of vertigo on patients with no headache, with/without headache, and with/without migraine. Mean and 95%
confidence interval are shown.
Fig. 3. Association of headache and migraine in patients with MD with neurological complaints regarding MD without headache (n = 330), with headache not
associated with vertigo attacks (n = 2267), with headache associated with vertigo attacks (n = 124), with migraine not associated with vertigo attacks (n = 115), and
with migraine associated with vertigo attacks (n = 75). The frequency distribution of the blurring of vision or double vision (Fig. 3a), stuttering or blurring of speech
(Fig. 3b), difficulties in swallowing (Fig. 3c), and tingling in the face or disturbance of sensitivity (Fig. 3d) are depicted. Mean and 95% confidence interval are shown.
The occurrence of complaints are rated from none to the present one.
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Please cite this article in press as: Pyykkö I, et al. Association between Ménière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
https://doi.org/10.1016/j.anl.2019.02.002
Fig. 5. Association of headache and migraine in patients with MD with neurological complaints for MD without headache (n = 330), with headache not associated
with vertigo attacks (n = 2267), with headache associated with vertigo attacks (n = 124), with migraine not associated with vertigo attacks (n = 115), and with migraine
associated with vertigo attacks (n = 75). The frequency distribution of the sense of coherence (Fig. 5a), anxiety (Fig. 5b) and fatigue (Fig. 5c) among patents with
Ménière’s disease are depicted. Mean and 95% confidence interval are shown. The anxiety and fatigue are rated in a 5-point scale from none to very intense.
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predict only 7% of the patients with MD into the two groups,
which highlights the heterogeneity of the disorder.
In logistic regression analysis (See Table 2), we established a
model in that three factors could predict VM statistically
significantly (p < 0.001). However, the model could only
predict 4.7% of the subject in correct class, which further
highlights the heterogeneity of the condition. The variables
found to be significant predictors in the model were duration of
vertigo attack (odds ratio 1.4), environmental pressure changeTable 2
Logistic regression to predict the Vestibular Migraine based on symptoms.
Variables in the equation
B S.E. Wa
Duration of vertigo attack .35 .117 8.77
Environmental pressure change .48 .136 12.4
Tingling in face or disturbance of sensitivity 1.34 .312 18.5
Constant 4.44 .471 88.8
Please cite this article in press as: Pyykkö I, et al. Association between M
https://doi.org/10.1016/j.anl.2019.02.002(odds ratio 1.6), and attack-wise tingling or paresthesia of the
face (odds ratio 3.8).
4. Discussion
The aim of the present study was to evaluate possible
differences in complaint characteristics of VM in patients with
MD as the evidence of previous studies indicates that VM often
overlaps with symptoms of MD [7,8,44,45]. We could confirm
that MD is frequently associated with headache. The differenceld df Sig. Exp. (B) 95% C.I.for EXP(B)
Lower Upper
 1 .003 1.416 1.125 1.782
4 1 <.0001 1.617 1.238 2.112
4 1 <.0001 3.836 2.080 7.072
9 1 <.0001 .012
énière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
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presented diagnosis of VM was applied according to recent
Bárány Society criteria on the temporal association of migraine
with vertigo spells. We found that patients classified as VM in
our study group (i.e., those with vertigo spells associated with
migraine) often reported complaints of severe MD symptoms,
had a reduced health-related quality of life, suffered more from
anxiety, had more neurological complaints, and had a reduced
sense of coherence. However, the models used to separate MD
from VM were without practical values as being able to only
explain 7% and 5% of the variance in decision tree and logistic
regression analyses, respectively. Furthermore, the results
indicate that migraine increases the severity of MD. In this line
our results support those as reviewed by Tabet and Saliba [17]
and by Phillips et al. [14].
The diagnostic criteria for VM were the product of an accord
between the classification committees of the IHS and the
Bárány Society for classification of VM [46] that would match
with the MD classification of the Bárány Society Committee
[6]. Nevertheless, there is still a concern in the scientific
community about the relevance of VM classification as an
independent disorder [14]. So far there is a limited number of
studies in which the classification between MD and VM are
based on statistical work up [17]. Most studies either describe
the association of migraine with vertigo, or of vertigo with
migraine. Neff et al. [21] studied 147 patients with VM, MD
and Ménière’s disease plus Vestibular Migraine (MDVM). The
lattermost group amounted to about 25% of their sample, and
the authors concluded that more specific diagnostic criteria was
needed to differentiate between these diseases and address their
coexistence. We could confirm that migraine (21%) and
headache (43%) are common in patients with MD in line with
others [7,8,47]. Hence, we support the suggestion by Dolowitz
[48] and Neff et al. [21] that headache could be added to the MD
as a supplementary complaint; in addition, comorbidity was
common between MD and VM, and that their symptoms
overlap. We propose that MD with migraine and VM are not
synonymous, although individual patients may meet the
diagnostic criteria for both conditions. In other words,
simultaneous presentation of definite VM and definite MD
making this an overlapping syndrome of two diseases has been
reported [49]. Such patients can be classified as “VM/MD
overlapping syndrome (VM/MD-OS)” as proposed by Mur-
ofushi et al. [49]
Anxiety is reported to be a common occurrence with VM.
The conjunction of migraine, vestibular symptoms, and anxiety
has been termed Migraine–Anxiety–Related Dizziness
(MARD) [44]. Phillips et al. [14] also indicated that both
migraine and vertigo share a common association with anxiety.
Anxiety has also been co-associated with peripheral vestibular
disorders such as MD [29,50]. The association between anxiety
and sense of coherence was strong, indicating that personality
trait is a strong predictor of anxiety as also indicated in MARD
[42]. In MD, mobility related symptoms and mood disorders in
a broad sense were the most significant determinants of vitality
and anxiety [50]. In the present study, we could confirm that
anxiety was increased among MD patients who had migraine
with frequent vertigo attacks. The same was true also for sensePlease cite this article in press as: Pyykkö I, et al. Association between M
https://doi.org/10.1016/j.anl.2019.02.002of coherence. In the study by Mendel et al. [51] on vertiginous
patients, a low sense of coherence did not correlate with vertigo,
but rather with the psychosocial stress and emotional distress
caused by the disease. In another study on MD, the sense of
coherence appears to reflect the patient’s attitude towards
illness and correlates with perceived good health [43]. Patients
with higher sense of coherence scores were more content with
their quality of life and this may partly explain why MD patients
with migraine experience the symptoms as more severe.
In MD, the endolymphatic hydrops signifies the disorder as
it is present in all patients with definite MD [1]. Light
microscopy showed no structural alteration in cochlear sensory
hair cells and innervation patterns that could account for the
symptoms of MD [52]. A detailed ultrastructural study of a
temporal bone using serial electron microscopy in a patient with
documented unilateral MD showed a considerable decrease in
afferent synapses at the base of both the inner and the outer hair
cells in the ear with MD as compared to the contralateral ear [4].
These findings may indicate that the reason for MD can be
neuronal in origin. Headache occurred more frequently among
patients with MD than in vestibular neuritis [47] and was related
to vertigo only in patients with MD, which was suggested to be
caused by endolymphatic hydrops, causing headache with
trigeminal nerve activation, subsequently leading to loss of
sensory neurons in the cochlea [53].
It is important to note that tension type headache among
others is very often associated with vertigo (See Headache
Classification Committee of the International Headache Society
[54]). Also, when reviewing studies of vertigo and migraine, the
most commonly associated migraine subtype was migraine
without aura (80%), and only 12% had migraine with aura
associated to vertigo [55]. Also, the duration of vertigo was less
than 5 min (which is the shortest duration of migraine aura) in
25% of patients. Among the patients with short-lasting attacks,
75% of patients had >5 attacks/day, which is most probably
related to neck muscle proprioceptive problems caused by
muscle tension. In another recent study, 25% of vertigo attacks
lasted less than 5 min and only 20% of vertigo attacks lasted
from 5 min to 1 h, which is the duration of migraine with aura
[56]. These cases might represent the basilar type migraine aura,
and support the idea that a portion of vertigo is associated
pathophysiologically to migraine.
4.1. Study limitations
The current study presents results of a population study
among MD to better understand the association between MD
and VM. However, the study has a few limitations. First, the
VM diagnosis relies on anamnestic self-reported data focusing
on migraine and vestibular symptoms. Those with headache
attacks associated with vertigo spells may represent probable
VM cases. Second, the diagnosis of migraine depended on
earlier diagnosis made by physicians, and probably also a
significant part of those who had headache might actually have
migraine. In a general population sample, 60% of migraine
sufferers were not aware that they had migraine [57], and in one
study only a fraction of migraine sufferers were diagnosed [58].
A specific questionnaire might be used to clarify this question,énière’s disease and vestibular migraine. Auris Nasus Larynx (2019),
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example, Samaan et al. [59] indicated that with a questionnaire,
the sensitivity of migraine is high (87%) but the specificity is
only modest (58%) when compared with a specialist's
diagnosis. On the contrary, by using a 36-page questionnaire,
Kallela et al. [60] demonstrated specificity of 99% and
sensitivity of 96% when compared with a telephone interview
of a specialist. Third, the diagnostic criteria for VM proposed by
the Bárány Society and the IHS [9] is different from ours as we
did not count the number of vertigo attacks in MD in numbers
but rather in the frequency of occurrence. This, in our opinion,
provides better perspectives of life long history. For these
reasons, study results should be interpreted with caution. Future
studies should try to use questionnaire-based diagnosis of
migraine and repeat the study to also include those patients
classified as experiencing headache in more specific headache
classes [54].
5. Conclusions
In the current literature, there is a significant lack of
understanding regarding symptom-based differentiation be-
tween MD and VM, and admittedly, diagnosis of VM remains a
challenge for neurologists and ENT specialists. Migraine and
headache were reported by 190 subjects (20.9%) and
391 subjects (42.9%) respectively in the current study. We
found that patients that could be classified as VM in the study
(i.e., those with frequent vertigo spells associated with
migraine) voiced more complaints of severe MD symptoms,
experienced a reduced health-related quality of life, suffered
more from anxiety, had more neurological complaints, and had
a reduced sense of coherence. Our study results confirm that
MD is frequently associated with headache. In addition, results
also indicate that migraine provokes the severity of MD.
However, we could not discern any complaints discriminating
between VM and MD that would allow reclassification of a
patient to MD or VM.
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